All articles tagged with #tetanus
Tetanus, a preventable disease caused by Clostridium tetani, is reappearing in the U.S. as vaccination rates dip; it can cause severe muscle spasms and even death if untreated. There were 38 reported cases in 2025—the most since 2006—prompting experts to warn that lower immunization could fuel more infections. Vaccines such as DTaP and Tdap remain the key prevention.
CDC reports rising tetanus cases in the US over the 2009–2023 surveillance period and four pediatric tetanus cases in 2024. Tetanus is caused by Clostridium tetani, not contagious, and prevents with vaccination and proper wound care. Symptoms can include jaw stiffness, painful muscle spasms, and breathing problems, and the disease can be fatal. Protection includes five routine tetanus-containing vaccines in childhood, boosters every 10 years for adults, boosted protection during pregnancy (Tdap), and seeking prompt care for deep puncture wounds or wounds contaminated by dirt or animal waste.
Tetanus cases are rising in the U.S. but remain rare; most infections occur in unvaccinated or under‑vaccinated individuals. A recent JAMA viewpoint notes 2025 saw 33 cases (up from 18 in 2023), underscoring that tetanus is preventable through vaccination and boosters. Health experts urge sticking to the recommended schedule and getting boosters after injuries to avert a painful, potentially deadly disease.
CDC and state health officials report four pediatric tetanus cases in 2024 among unvaccinated children in Idaho, Minnesota, Missouri, and Wisconsin. In two cases, parents refused post-exposure tetanus immunoglobulin and vaccination; all children were hospitalized for lengthy stays (average about 25 days) and received TIG and an initial TTCV dose, with only one child later completing the vaccine series. No deaths occurred. The report highlights missed prevention opportunities—no prior TTCV, delays in wound care, and refusal of prophylaxis—underscoring the importance of timely wound care and up-to-date tetanus vaccination to prevent disease.
US tetanus surveillance from 2009–2023 recorded 402 cases and 37 deaths (mean incidence 0.08 per million). Most cases occurred in adults (median age 40; 86% ≥18), with higher incidence in males; deaths declined by over 99%. The burden persists especially among unvaccinated/undervaccinated individuals, reflecting suboptimal adult tetanus vaccination coverage (Tdap/TTCV ~57–70%). The National Notifiable Diseases Surveillance System monitors trends, wound management, and vaccine use to guide prevention efforts.
Doctors are concerned about rising tetanus cases due to declining vaccination rates, which are exacerbated by climate change-related natural disasters increasing injury risks. Tetanus, a preventable disease, can cause severe muscle spasms and death, but vaccination costs are low compared to treatment expenses. Recent cases highlight the importance of maintaining vaccination schedules, especially in disaster-prone areas.
New research suggests that adults may not need routine tetanus and diphtheria booster shots if childhood vaccination coverage remains high, potentially saving the U.S. about $1 billion annually, with evidence from the UK supporting long-lasting immunity from childhood vaccines.
Research suggests that US adults may not need routine tetanus and diphtheria booster shots if childhood vaccination coverage remains high, potentially saving billions annually and aligning US guidelines with WHO recommendations, as immunity from childhood vaccines appears to last over 30 years with minimal disease incidence.
New research from Oregon Health & Science University suggests that adults who are vaccinated in childhood may not need tetanus and diphtheria booster shots every 10 years, as immunity could last for 30 years or more, potentially leading to significant cost savings and a revision of current vaccination guidelines.
Stanford University scientists have developed a topical vaccine using the skin bacterium Staphylococcus epidermidis, which could replace traditional needle-based vaccinations. This innovative approach, tested in mice, showed that the bacterium can trigger a strong immune response, producing antibodies against diseases like tetanus without causing inflammation or pain. The research suggests potential for a wide range of applications, including protection against viruses and other pathogens, with plans to advance to clinical trials in the near future.
The Wyoming Department of Health's vaccine ad campaign, titled "A Hairy Time," has gained national attention for its darkly humorous approach. Inspired by historical newspaper articles about tetanus-related deaths, the ad features a graveside service where a man died from shaving. The campaign aims to address a decline in vaccine compliancy in Wyoming, partly due to anti-vaccine disinformation and complacency. The ad highlights the importance of vaccines in controlling or eradicating once-common diseases like polio, Hepatitis B, and tetanus. The cinematic ad, funded by federal funding, combines humor and beautiful visuals to engage viewers and promote vaccine awareness.
The increase in Sudden Infant Death Syndrome (SIDS) since the 1970s has led to questions about a possible link to the diphtheria, tetanus, and acellular pertussis (DTAP) vaccine. Specifically, the tetanus component of the vaccine is being examined, as data has raised concerns about why infants are required to take it.